Ativan (lorazepam) is typically detectable in urine for up to six days after a single dose. Its primary metabolite can be detected for even longer, up to nine days. For people who take Ativan regularly or at high doses, urine tests may pick it up for a week or more beyond the last dose.
Detection Window After a Single Dose
After taking one dose of Ativan, urine concentrations peak at around 24 hours, then gradually decline. In controlled studies, urine tested positive for lorazepam over 144 hours (six days), with concentrations at the tail end dropping to just 2 to 4 ng/mL. That’s a narrow margin, and whether a test catches it at that point depends on the lab’s sensitivity threshold.
Most clinical laboratories set their screening cutoff for benzodiazepines at 200 or 300 ng/mL. At those levels, a standard immunoassay might only detect Ativan for the first two to four days after use. More sensitive confirmatory testing can pick up trace amounts for the full six-day window or slightly beyond.
How Regular Use Extends the Timeline
If you’ve been taking Ativan consistently over weeks or months, the drug and its byproducts build up in your system. Your body develops tolerance, which paradoxically slows elimination. In these cases, urine tests may detect lorazepam for a week or longer after the last dose, with metabolites potentially showing up for nine days or more.
The difference comes down to accumulation. Ativan’s main metabolite is processed by the kidneys but can reach plasma concentrations that actually exceed the parent drug. With repeated dosing, more of this metabolite circulates and takes longer to fully clear.
Why the Timeline Varies From Person to Person
Ativan has an average elimination half-life of about 14 hours, meaning it takes roughly that long for your body to clear half of a dose. But individual variation is significant. Several factors push that number higher or lower.
Kidney function is the biggest variable. Since Ativan’s metabolite is eliminated primarily through the kidneys, any reduction in kidney function slows the process considerably. In people with kidney impairment, the metabolite’s half-life increases by about 55%. For people on dialysis, it more than doubles, increasing by 125% compared to people with normal kidney function.
Age plays a role largely because kidney and liver function tend to decline with age. Ativan is processed in the liver before its byproducts are sent to the kidneys for excretion, so reduced function in either organ extends detection time. Body composition, hydration, and overall metabolic rate also contribute, though to a lesser degree than organ function.
Standard Drug Tests Often Miss Ativan
Here’s something many people don’t realize: standard urine drug screens frequently fail to detect Ativan even when it’s present. The typical workplace or clinical immunoassay is designed to catch the most common benzodiazepines, but lorazepam doesn’t always cross-react well with these tests. SAMHSA has noted that standard panels may not reliably detect anxiolytics like certain benzodiazepines, including at low therapeutic doses.
The American Society of Addiction Medicine has flagged this as a known limitation. Immunoassays vary by manufacturer, and some simply aren’t sensitive enough to detect therapeutic-level doses of Ativan. This means false negatives are a real possibility, where the drug is in your system but the test reads negative.
Confirmatory testing using gas chromatography-mass spectrometry is far more accurate, with near-perfect specificity and the ability to detect much lower concentrations. If a lab runs this type of follow-up test, it will reliably identify lorazepam and extend the effective detection window closer to that six-to-nine-day range.
False Positives From Other Medications
On the flip side, certain medications can trigger a positive benzodiazepine result on an immunoassay even if you haven’t taken Ativan or any similar drug. Two well-documented culprits are oxaprozin (an anti-inflammatory pain reliever sold as Daypro) and sertraline (the antidepressant sold as Zoloft). These medications cross-react with the antibodies used in the screening test, producing a false positive that would need confirmatory testing to sort out.
If you’re taking either of these and face a urine drug test, it’s worth mentioning them beforehand so the results can be interpreted correctly.
Quick Reference by Usage Pattern
- Single therapeutic dose: Detectable for roughly 2 to 6 days, depending on the test’s sensitivity
- Short-term use (days to a few weeks): Detectable for approximately 5 to 7 days after the last dose
- Chronic or high-dose use: Detectable for 7 to 9+ days, potentially longer with kidney impairment
These ranges assume a standard immunoassay with a 200 or 300 ng/mL cutoff. More sensitive confirmatory tests will push toward the higher end of each range.